See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261249_2019_AGILE_THERAPEUTICS_INC.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001261249')"} |
Graph
Absolute values for 0001261249, AGILE THERAPEUTICS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 8,458,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 13,916,000 |
| 3 | remainder_Assets | 18,000 |
| 4 | LiabilitiesCurrent | 2,218,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,739,000 |
| 9 | ResearchAndDevelopmentExpense | 9,777,000 |
| 10 | remainder_Expenses | 542,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -721,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 22,392,000 |
| 1 | Liabilities | 2,218,000 |
| 2 | Expenses | 19,058,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 20,174,000 |
| 5 | NetIncome | -19,779,000 |
| 6 | ComprehensiveNetIncome | -19,779,000 |
| 7 | BaseVar | 22,194,500 |
| 8 | EconomicCapitalRatio | 1.21 |